Medizinische Klinik-Innenstadt, Ludwig Maximilians University, Munich, Germany.
J Neurotrauma. 2011 Sep;28(9):1693-8. doi: 10.1089/neu.2011.1887. Epub 2011 Aug 29.
Clinical studies have demonstrated that traumatic brain injury (TBI) and aneurysmal subarachnoid hemorrhage (SAH) are frequent causes of long-term disturbances of hypothalamo-pituitary function. This study aimed to assess the prevalence and associated factors of post-traumatic hypopituitarism in a large national registry of patients with TBI and SAH. Data were collected from 14 centers in Germany and Austria treating patients for TBI or SAH and performing endocrine assessments. Data were collected using a structured, internet-based study sheet, obtaining information on clinical, radiological, and hormonal parameters. A total of 1242 patients (825 TBI, age 43.5±19.7 years; 417 SAH, age 49.7±11.8 years) were included. We studied the prevalence of hypopituitarism reported based on different definitions of laboratory values and stimulation tests. Stimulation tests for the corticotropic and somatotropic axes were performed in 26% and 22% of the patients, respectively. The prevalence of hypopituitarism in the chronic phase (at least 5 months after the event) by laboratory values, physician diagnoses, and stimulation tests, was 35%, 36%, and 70%, respectively. Hypopituitarism was less common in the acute phase. According to the frequency of endocrine dysfunction, pituitary hormone secretion was impaired in the following sequence: ACTH, LH/FSH, GH, and TSH. TBI patients with abnormal stimulation tests had suffered from more severe TBI than patients with normal stimulation tests. In conclusion, our data confirm that hypopituitarism is a common complication of TBI and SAH. It is possible that patients with a higher likelihood of hypopituitarism were selected for endocrine stimulation tests.
临床研究表明,创伤性脑损伤(TBI)和蛛网膜下腔出血(SAH)是导致下丘脑-垂体功能长期紊乱的常见原因。本研究旨在评估创伤性脑损伤和 SAH 患者大型国家登记处患者发生创伤后垂体功能减退症的患病率和相关因素。数据来自德国和奥地利的 14 个中心,这些中心治疗 TBI 或 SAH 患者并进行内分泌评估。使用基于互联网的结构化研究表收集数据,获取临床、影像学和激素参数的信息。共纳入 1242 例患者(825 例 TBI,年龄 43.5±19.7 岁;417 例 SAH,年龄 49.7±11.8 岁)。我们根据不同的实验室值和刺激试验定义研究了垂体功能减退症的患病率。促皮质激素和生长激素轴的刺激试验分别在 26%和 22%的患者中进行。根据实验室值、医生诊断和刺激试验,慢性期(事件发生后至少 5 个月)的垂体功能减退症患病率分别为 35%、36%和 70%。急性期的垂体功能减退症较少见。根据内分泌功能障碍的频率,垂体激素分泌受到以下顺序的影响:ACTH、LH/FSH、GH 和 TSH。刺激试验异常的 TBI 患者比刺激试验正常的患者遭受了更严重的 TBI。总之,我们的数据证实垂体功能减退症是 TBI 和 SAH 的常见并发症。可能选择了更有可能发生垂体功能减退症的患者进行内分泌刺激试验。